Replication of the VERO Osteoporosis Trial in Healthcare Claims Data
Condition: Osteoporosis Interventions: Drug: Teriparatide; Drug: Risedronate Sponsor: Brigham and Women's Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2021 Category: Research Source Type: clinical trials
Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).
Conditions: Secondary Hyperparathyroidism; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis; Hypocalcemia; Hypoparathyroidism Intervention: Drug: Teriparatide Sponsor: Saint Petersburg State University, Russia Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2021 Category: Research Source Type: clinical trials